Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 Apr;39(4):350–356. doi: 10.1136/jnnp.39.4.350

Comparison of dantrolene sodium and diazepam in the treatment of spasticity.

R T Schmidt, R H Lee, R Spehlmann
PMCID: PMC492284  PMID: 778344

Abstract

The effects of dantrolene sodium and diazepam were compared in a double crossover study of 42 patients with spasticity due to stable multiple sclerosis. Both drugs reduced the findings of spasticity, clonus, and hyperreflexia, and the complaints of muscle stiffness and cramping. Each drug had different side effects which suggest indications and contraindications for its use in spastic patients.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burke D., Andrews C. J., Knowles L. The action of a GABA derivative in human spasticity. J Neurol Sci. 1971 Oct;14(2):199–208. doi: 10.1016/0022-510x(71)90089-x. [DOI] [PubMed] [Google Scholar]
  2. Cartlidge N. E., Hudgson P., Weightman D. A comparison of baclofen and diazepam in the treatment of spasticity. J Neurol Sci. 1974 Sep;23(1):17–24. doi: 10.1016/0022-510x(74)90137-3. [DOI] [PubMed] [Google Scholar]
  3. Chipman M., Kaul S., Lambie M. Efficacy of dantrolene sodium in the treatment of spasticity. Dis Nerv Syst. 1974 Sep;35(9):427–431. [PubMed] [Google Scholar]
  4. Chyatte S. B., Basmajian J. V. Dantrolene sodium: long-term effects in severe spasticity. Arch Phys Med Rehabil. 1973 Jul;54(7):311–315. [PubMed] [Google Scholar]
  5. Chyatte S. B., Birdsong J. H., Bergman B. A. The effects of dantrolene sodium on spasticity and motor performance in hemiplegia. South Med J. 1971 Feb;64(2):180–185. doi: 10.1097/00007611-197102000-00011. [DOI] [PubMed] [Google Scholar]
  6. Corbett M., Frankel H. L., Michaelis L. A double blind, cross-over trial of Valium in the treatment of spasticity. Paraplegia. 1972 May;10(1):19–22. doi: 10.1038/sc.1972.4. [DOI] [PubMed] [Google Scholar]
  7. Ellis K. O., Bryant S. H. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):107–109. doi: 10.1007/BF00501011. [DOI] [PubMed] [Google Scholar]
  8. Ellis K. O., Carpenter J. F. A comparative study of dantrolene sodium and other skeletal muscle relaxants with the Straub tail mouse. Neuropharmacology. 1974 Mar;13(3):211–214. doi: 10.1016/0028-3908(74)90109-9. [DOI] [PubMed] [Google Scholar]
  9. Ellis K. O., Carpenter J. F. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant. Naunyn Schmiedebergs Arch Pharmacol. 1972;275(1):83–94. doi: 10.1007/BF00505069. [DOI] [PubMed] [Google Scholar]
  10. From A., Heltberg A. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis. Acta Neurol Scand. 1975 Feb;51(2):158–166. doi: 10.1111/j.1600-0404.1975.tb01366.x. [DOI] [PubMed] [Google Scholar]
  11. Gelenberg A. J., Poskanzer D. C. The effect of dantrolene sodium on spasticity in multiple sclerosis. Neurology. 1973 Dec;23(12):1313–1315. doi: 10.1212/wnl.23.12.1313. [DOI] [PubMed] [Google Scholar]
  12. Herman R., Mayer N., Mecomber S. A. Clinical pharmaco--physiology of dantrolene sodium. Am J Phys Med. 1972 Dec;51(6):296–311. [PubMed] [Google Scholar]
  13. KURTZKE J. F. FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS. Neurology. 1965 Jul;15:654–661. doi: 10.1212/wnl.15.7.654. [DOI] [PubMed] [Google Scholar]
  14. KUZMA J. W., TOURTELLOTTE W. W., REMINGTON R. D. QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. II. SOME STATISTICAL CONSIDERATIONS OF A BATTERY OF TESTS. J Chronic Dis. 1965 Mar;18:303–311. doi: 10.1016/0021-9681(65)90157-8. [DOI] [PubMed] [Google Scholar]
  15. Kuzma J. W., Namerow N. S., Tourtellotte W. W., Sibley W. A., Kurtzke J. F., Rose A. S., Dixon W. J. An assessment of the reliability of three methods used in evaluating the status of multiple sclerosis patients. J Chronic Dis. 1969 Apr;21(11):803–814. doi: 10.1016/0021-9681(69)90026-5. [DOI] [PubMed] [Google Scholar]
  16. Ladd H., Oist C., Jonsson B. The effect of Dantrium on spasticity in multiple sclerosis. Acta Neurol Scand. 1974;50(4):397–408. doi: 10.1111/j.1600-0404.1974.tb02790.x. [DOI] [PubMed] [Google Scholar]
  17. Landau W. M. Editorial: Spasticity: the fable of a neurological demon and the emperor's new therapy. Arch Neurol. 1974 Oct;31(4):217–219. doi: 10.1001/archneur.1974.00490400031001. [DOI] [PubMed] [Google Scholar]
  18. Lenman J. A. Drugs in the management of spasticity. Dev Med Child Neurol. 1971 Jun;13(3):386–388. doi: 10.1111/j.1469-8749.1971.tb03278.x. [DOI] [PubMed] [Google Scholar]
  19. Mayer N., Necomber S. A., Herman R. Treatment of spasticity with dantrolene sodium. Am J Phys Med. 1973 Feb;52(1):18–29. [PubMed] [Google Scholar]
  20. Nathan P. W. Spasticity and its amelioration. Mod Trends Neurol. 1970;5(0):41–59. [PubMed] [Google Scholar]
  21. Pedersen E., Arlien-Soborg P., Grynderup V., Henriksen O. Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba). Acta Neurol Scand. 1970;46(3):257–266. doi: 10.1111/j.1600-0404.1970.tb05791.x. [DOI] [PubMed] [Google Scholar]
  22. Pedersen E., Arlien-Soborg P., Mai J. The mode of action of the gaba derivative baclofen in human spasticy. Acta Neurol Scand. 1974;50(6):665–680. doi: 10.1111/j.1600-0404.1974.tb02813.x. [DOI] [PubMed] [Google Scholar]
  23. Peirson G. A., Fowlks E. W., King P. S. Long-term follow-up on the use of diazepam in the treatment of spasticity. Am J Phys Med. 1968 Jun;47(3):143–149. [PubMed] [Google Scholar]
  24. TOURTELLOTTE W. W., HAERER A. F., SIMPSON J. F., KUZMA J. W., SIKORSKI J. QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL. Ann N Y Acad Sci. 1965 Mar 31;122:480–505. doi: 10.1111/j.1749-6632.1965.tb20231.x. [DOI] [PubMed] [Google Scholar]
  25. Wilson L. A., McKechnie A. A. Oral diazepam in the treatment of spasticity in paraplegia a double-blind trial and subsequent impressions. Scott Med J. 1966 Feb;11(2):46–51. doi: 10.1177/003693306601100202. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES